HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Kimura Selected Research

Annexin A4

1/2015Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives.
4/2014Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers.
11/2009Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Kimura Research Topics

Disease

122Neoplasms (Cancer)
05/2022 - 06/2003
74Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 05/2009
45Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2007
26Endometrial Neoplasms (Endometrial Cancer)
06/2022 - 05/2008
25Carcinoma (Carcinomatosis)
11/2018 - 04/2007
14Pre-Eclampsia (Preeclampsia)
02/2022 - 04/2009
14Ovarian Epithelial Carcinoma
11/2021 - 11/2009
14Neoplasm Metastasis (Metastasis)
11/2021 - 05/2005
12Hemorrhage
04/2022 - 09/2008
10Placenta Accreta
01/2021 - 01/2012
8Adenocarcinoma
10/2017 - 09/2010
8Leiomyoma (Uterine Fibroids)
01/2016 - 01/2008
7Infections
12/2022 - 05/2010
7Postpartum Hemorrhage
09/2021 - 10/2018
7Hypoxia (Hypoxemia)
01/2020 - 04/2009
6Fetal Growth Retardation (Intrauterine Growth Retardation)
11/2021 - 05/2014
6Placenta Previa
01/2021 - 01/2012
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2018 - 04/2010
6Endometrioid Carcinoma
04/2016 - 05/2010
5Ascites
01/2022 - 10/2002
5Disease Progression
01/2022 - 04/2010
5Cysts
11/2021 - 12/2005
4Carcinogenesis
11/2021 - 05/2008
4Premature Birth (Birth, Premature)
05/2021 - 11/2004
4Chorioamnionitis
03/2016 - 03/2004
4Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 02/2010
3Uterine Cervical Dysplasia
12/2022 - 05/2012
3Endometriosis
01/2022 - 08/2016
3Inflammation (Inflammations)
01/2022 - 11/2013
3Gestational Diabetes (Gestational Diabetes Mellitus)
03/2021 - 11/2007
3Choriocarcinoma
01/2018 - 04/2009
3Osteoporosis
01/2017 - 01/2009
3Lymphatic Metastasis
12/2015 - 01/2011

Drug/Important Bio-Agent (IBA)

18PlatinumIBA
11/2021 - 05/2009
17Paclitaxel (Taxol)FDA LinkGeneric
05/2022 - 05/2009
17Proteins (Proteins, Gene)FDA Link
08/2019 - 10/2002
16Carboplatin (JM8)FDA LinkGeneric
05/2022 - 05/2009
15Papillomavirus Vaccines (HPV Vaccines)IBA
12/2022 - 06/2015
13Cisplatin (Platino)FDA LinkGeneric
09/2021 - 12/2008
11AntigensIBA
01/2022 - 11/2007
11Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 04/2010
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 03/2007
9Indicators and Reagents (Reagents)IBA
09/2021 - 07/2011
9Pharmaceutical PreparationsIBA
01/2020 - 04/2007
9Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2010
8VaccinesIBA
12/2022 - 11/2009
8SuspensionsIBA
01/2022 - 05/2005
8MicroRNAs (MicroRNA)IBA
01/2020 - 05/2013
7Monoclonal AntibodiesIBA
06/2022 - 12/2008
7Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 12/2011
7taxaneIBA
10/2018 - 05/2009
6Tyrosine (L-Tyrosine)FDA Link
01/2019 - 04/2007
6nedaplatinIBA
08/2015 - 12/2009
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2022 - 01/2011
5CytokinesIBA
01/2020 - 11/2013
5Interleukin-6 (Interleukin 6)IBA
01/2019 - 06/2010
4AnthracyclinesIBA
05/2022 - 04/2011
4Tadalafil (Cialis)FDA Link
11/2021 - 10/2018
4AntibodiesIBA
01/2021 - 10/2014
4Estrogens (Estrogen)FDA Link
11/2019 - 01/2012
4Neutralizing AntibodiesIBA
03/2019 - 07/2014
4Biological ProductsIBA
03/2019 - 08/2011
4IntegrinsIBA
10/2017 - 01/2012
3Epirubicin (Ellence)FDA LinkGeneric
05/2022 - 04/2011
3Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
02/2022 - 01/2013
3Hemoglobins (Hemoglobin)IBA
01/2022 - 03/2015
3Peptides (Polypeptides)IBA
01/2022 - 11/2009
3C-Reactive ProteinIBA
01/2022 - 05/2010
3GemcitabineFDA Link
11/2021 - 09/2012
3Immunoconjugates (Immunoconjugate)IBA
09/2021 - 01/2018
3LipidsIBA
08/2019 - 02/2015
3Oxytocin (Pitocin)FDA LinkGeneric
02/2018 - 02/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 02/2010
3EverolimusFDA Link
04/2016 - 09/2009
3Bevacizumab (Avastin)FDA Link
04/2015 - 12/2008
3Annexin A4IBA
01/2015 - 11/2009
3Tumor Biomarkers (Tumor Markers)IBA
10/2013 - 06/2010
3Oxygen (Dioxygen)IBA
01/2013 - 09/2009
3Messenger RNA (mRNA)IBA
04/2009 - 02/2008

Therapy/Procedure

60Therapeutics
04/2022 - 01/2008
36Drug Therapy (Chemotherapy)
01/2022 - 05/2009
31Hysterectomy
01/2022 - 06/2003
28Radiotherapy
09/2021 - 05/2009
12Chemoradiotherapy
09/2021 - 12/2009
11Lymph Node Excision (Lymph Node Dissection)
03/2022 - 10/2012
8Brachytherapy
05/2021 - 01/2010
7Conservative Treatment
01/2022 - 01/2006
7Cesarean Section (Caesarean Section)
02/2017 - 01/2011
6Combination Drug Therapy (Combination Chemotherapy)
10/2018 - 12/2011
5Aftercare (After-Treatment)
01/2022 - 08/2010
5Uterine Artery Embolization
01/2021 - 01/2016
5Immunotherapy
01/2020 - 11/2009
5Adjuvant Radiotherapy
03/2013 - 11/2011
4Cytoreduction Surgical Procedures
10/2012 - 03/2010
3Laparotomy
03/2022 - 03/2011
3Kampo Medicine (Kampo)
01/2022 - 01/2018
3Salpingo-oophorectomy
11/2019 - 05/2015
3Consolidation Chemotherapy
01/2017 - 12/2011
3Salvage Therapy
11/2016 - 10/2013
3Uterine Myomectomy
06/2016 - 01/2008